Insights from Egyptian ticagrelor study in patients who presented with acute coronary syndrome (ETS in ACS)

Insights from Egyptian ticagrelor study in patients who presented with acute coronary syndrome (ETS in ACS)

Abstract Background Dual antiplatelet therapy with aspirin and a thienopyridine is used to prevent thrombotic complications of acute coronary syndrome (ACS) and percutaneous coronary interventions (PCI). Ticagrelor is an oral, reversible inhibitor of the adenosine diphosphate receptor P2Y12 with a f...

Full description

Bibliographic Details
Main Authors: Hesham S. Taha, Hossam Kandil, Nabil Farag, Amr Zaki, Hossam Mahrous, Mirna M. Shaker
Format: Article
Language:English
Published: SpringerOpen 2022-06-01
Series:The Egyptian Heart Journal
Subjects:
Antiplatelet therapy
Acute coronary syndrome
Cardiovascular death
Bleeding
Online Access:https://doi.org/10.1186/s43044-022-00290-w

Internet

https://doi.org/10.1186/s43044-022-00290-w

Similar Items